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Galli-Galli disease is a rare acantholytic variant of Dowling-Degos disease, with few cases reported in the literature. We describe a
case of Galli-Galli disease and review the literature.
1. Introduction
Galli-Galli disease (GGD) is a very rare variant of the
Dowling-Degos disease (DDD) with the histologic finding of
focal acantholysis. It was originally reported by Bardach et
al. in 1982, who described the disease in two brothers and
named it eponymically after this family [1].
2. Case Report
A previously healthy 67-year-old Caucasian woman pre-
sented with a 15-year history of widespread skin lesions.
She had recurrent pruritic papular eruptions and slowly
progressing brownish lentigo-like macules. The skin lesions
began on the trunk and then became generalized, involving
the extensor and flexural surfaces of extremities, including
the back of the hands, neck, and trunk. Clinical examination
revealed numerous generalized symmetrically distributed
brownish macules and some pruritic, hyperkeratotic, ery-
thematous papules (Figure 1). The face, palms, and soles
were spared, and she had no nail, hair, teeth, or mucosal
alterations. There was no atrophic or hypopigmented lesions.
No family history of similar lesions was known. She
was previously treated with topical corticosteroids without
improvement. Laboratory examinations demonstrated no
abnormalities. Histopathologic examination of three biopsy
specimens revealed digitiform epithelial downgrowths of
the rete ridges, with hyperpigmentation of the basal layer
confined to the tips of the rete ridges. Multiple foci of
suprabasilar acantholysis were also observed (Figure 2) and
a mixed dermal inflammatory infiltrate. In one of the biopsy
specimens, we found acantholytic and dyskeratotic cells
(Figure 2(b)). Direct immunofluorescence was negative.
Taken together, clinical and pathological data suggested a
diagnosis of Galli-Galli disease. Treatment was very diﬃcult
with only short-term partial improvement using acitretin
(25mg/day) and topical corticosteroids.
3. Discussion
Galli-Galli disease is a benign but very pruritic and unaes-
thetic genodermatosis. Its mode of inheritance is believed to
be autosomal dominant with variable penetrance, but it can
occur sporadically [2, 3], as in our patient. As with DDD
it is believed to be linked to mutations in the KRT5 gene
[3–6]. Clinically it is characterized by reticulated hyperpig-
mentation predominantly aﬀecting the flexures along with
pruritic, erythematous, scaly papules, similar to the DDD.
Histopathologic examination reveals digitiform elongation
of the rete ridges seen in DDD, together with suprabasal focal
acantholysis [2–9].
A few patients have been described in the literature. A
literature search revealed 9 previous case reports of GGD,
with a total of 17 patients (Table 1). According to the
reported cases, the age range of presentation is 15 to 67 years,
11 patients were male, and 6 were female. All the patients
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Figure 1: Polymorphous dermatosis characterized by disseminated erythematous papules and plaques and multiple brown macules.
(a) (b)
(c) (d)
Figure 2: Hematoxylin and eosin. (a) Discrete hyperkeratosis, elongated rete ridges with digitiform projections, and focal acantholysis with
formation of linear clefts. Presence of mixed dermal inflammatory infiltrate. (b) Dyskeratotic cells in the interior of a acantholytic cleft. (c)
and (d) Digitiform elongation of the rete ridges, with hyperpigmentation of the basal layer confined to the tips of the rete ridges. Suprabasal
acantholysis.
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Table 1: Reported cases of Galli-Galli disease.
Author/year Age Sex Description Acantholysis Dyskeratosis
Bardach et al.1982 [1]
19 M Reticulated hyperpigmentation of the ace and
neck and pruritic, erythematous papules on
flexures, trunk, and extremities
+ +
15 M + +
Mittag et al. [10]
56 M
Hyperkeratotic papules Hyperpigmentation of
the folds
+ −
51 M + −
46 F No biopsy was performed
17 M
Rutten and Strauss1995 [7] 24 M
Reticulated hyperpigmentation, comedo-like
lesions
+ ?
De Deene and Schulze 1996 [9] 59 F
Hyperpigmentation of the main folds and trunk,
pruritic papules
+ ?
Braun-Falco et al. 2001 [2] 53 M
Reticulate hyperpigmentation of the main folds,
pruritic papules on the neck, trunk, axilla, and
hands
+ −
El Shabrawi-Caelen et al. 2007 [6]
65 F Recurrent maculopapular eruption involving the
trunk and lower extremities
+ +
67 F + −
Sprecher et al. 2007 [5] 43 F
Pruritic papular rash of the flexural areas and
reticulate pigmentation
+ −
Gilchrist et al. 2008 [3] 41 M
Hyperpigmentation of the flexures, pruritic
papules on the trunk, and proximal extremities
+ −
Mu¨ller et al. 2009 [8]
41 M
Erythematous macules and reticulate
pigmentation of the main folds, without pruritus
+ −
52 M + −
48 F + −
25 M
Pigmented macules on the trunk and neck,
erythematous, pruritic papules, and perioral scars
and comedo-like lesions
+ −
in the reports had reticulated hyperpigmentation in the
flexural areas, with the exception of one. In our patient, the
characteristic hyperpigmentation of the axillae and inguinal
region could not be detected, rendering a diagnosis of GGD
diﬃcult.
In 15 of the 17 cases a skin biopsy was performed, and in
all of this cases acantholysis was identified, but dyskeratosis
was present in only 3 cases. In our case we also identified
dyskeratotic cells in one of the fragments, closely resembling
features of Darier’s or Grover’s diseases. However, Darier’s
disease could be ruled out by the presence of areas of digitate
proliferations of the rete ridges, clinically it starts early,
lentigo-like macules are rare, and it is commonly associated
with nail and mucous membrane involvement that was
absent in our patient. In Grover’s disease involvement of
the distal extremities, as in our patient, and the presence of
brown lentigo-like macules are not common. Histologically,
areas of lentiginous elongations of the rete ridges are not
observed in Grover’s disease.
Acantholysis is a sine qua non condition for the diagnosis
of Galli-Galli disease [2–9], but dyskeratosis is not an
essential finding [2, 3], although its presence does not
exclude the diagnosis.
Because of the overlap of clinical features, to the majority
of authors GGD is best considered as an acantholytic
variant of Dowling-Degos disease rather than an entity of
its own [2, 3]; however, some authors defend that if one
accepts the histopathological finding of acantholysis as a
pathognomonic feature, GGD should be classified as its own
disease entity [8].
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